More PYC Therapeutics Limited news
PYC Therapeutics LimitedASX: PYC

FPP Results Effective in Delivering Peptide Cancer Vaccine

Jan 8, 2018 at 3:00 AM EST · Issued by PYC Therapeutics Limited

Filed with ASX · Jan 8, 2018 at 3:00 AM EST · 4 pages · English

On 6ix: 6ix.com/news/fpp-results-effective-in-delivering-peptide-cancer-vaccine

PYC Therapeutics Limited on 6ix

In the deck

  • Phylogica — BioShowcase (January 2018)21 slidesJan 9, 2018

Earlier from PYC Therapeutics

  • Phylogica Strategic Update - Pivot to PlatformDec 3, 2017
  • Quarterly Update and Appendix 4COct 25, 2017
  • PYC Granted US Patent for Peptides Entering Brain CellsOct 4, 2017
  • New Delivery Vehicles Show Improved Performance Inside CellsSep 5, 2017
  • Appendix 4E - Preliminary Final Report 30 June 2017Aug 31, 2017

Later from PYC Therapeutics

  • Federal R&D Tax Credit ReceivedJan 11, 2018
  • Dec Quarterly Update and Appendix 4CJan 31, 2018
  • Dec 2017 Half-year financial statements & Appendix 4DFeb 28, 2018
  • Cre Enzyme Delivery Provides Validation & Strategic ValueMar 1, 2018
  • Changes to Board and ManagementApr 11, 2018
All PYC Therapeutics news releases↗

Follow PYC Therapeutics into a list and get an email when it puts out news.

Follow PYC Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer